Chungyeul Kim - Concepedia

Author

Chungyeul Kim

Korea University Medical Center ORCID

Also Known As

CHUNGYEUL KIM, Chung Yeul Kim, Chung-Yeul Kim, Chungyeul Kim, Kim, Chungyeul

107

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

Korea University Medical Center Korea University NSABP Foundation University of Pittsburgh Allegheny General Hospital

About

Chungyeul Kim is an author at Korea University Medical Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	156
2	Engineering	2	2	43
3	Health Sciences	2	2	26
4	Biostatistics	1	1	30
5	Cell Biology	1	1	39

Chungyeul Kim

Publications

10.4K

Citations

H-Index

Page 1

	Year	Citations
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Soonmyung Paik, Steven Shak, Gong Tang, New England Journal of Medicine	2004	6.3K
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Soonmyung Paik, Gong Tang, Steven Shak, Journal of Clinical Oncology	2006	2.6K
Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value Patrick G. Gavin, Linda H. Colangelo, Debora Fumagalli, Clinical Cancer Research	2012	312
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Soonmyung Paik, Gong Tang, Steven Shak, Journal of Clinical Oncology	2023	154
Estrogen Receptor (<i>ESR1</i>) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer Chungyeul Kim, Gong Tang, Katherine L. Pogue–Geile, Journal of Clinical Oncology	2011	145
Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31 Katherine L. Pogue–Geile, Chungyeul Kim, Jong‐Hyeon Jeong, JNCI Journal of the National Cancer Institute	2013	113
Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial Lajos Pusztai, Jong‐Hyeon Jeong, Yun Yun Gong, Journal of Clinical Oncology	2009	86
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005) Edith A. Perez, Michael F. Press, Amylou C. Dueck, Breast Cancer Research and Treatment	2013	78
Cytoplasmic Estrogen Receptor in Breast Cancer Allison W. Welsh, Donald R. Lannin, Gregory Young, Clinical Cancer Research	2011	63
Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer Sherry X. Yang, Joseph P. Costantino, Chungyeul Kim, Journal of Clinical Oncology	2010	60

Page 1